Aneo BidCo has obtained all necessary approvals from authorities for the recommended cash offer to the shareholders of Arise

Aneo BidCo has received all required regulatory clearances, including competition approval and clearance from the Swedish Inspectorate of Strategic Products (FDI screening), for its recommended cash offer to Arise AB shareholders, removing regulatory approvals as a condition for completion. The offer document was published 1 December 2025; the acceptance period runs from 2 December to 30 December 2025 (15:00 CET) and settlement is expected around 12 January 2026, with Aneo BidCo reserving the right to extend or postpone. Aneo Holding AS (owned 50% by TrønderEnergi and 50% by HitecVision-managed funds) indirectly wholly owns Aneo BidCo; all other offer conditions remain as set out in the offer document.

Analysis

Market structure: Aneo’s cleared, recommended cash offer materially de-risks regulatory uncertainty for Arise (ARISE.ST) and compresses execution risk — the acceptance window (2–30 Dec 2025) and expected settlement (~12 Jan 2026) create a finite 10–40 day arbitrage. Winners: Aneo/HitecVision/TrønderEnergi (consolidation, control); Arise shareholders who tender at the offer price; short-term equity arbitrageurs. Losers: public float/liquidity providers in Swedish renewables (fewer free‑float shares post-deal), and small-cap developers who lose a public comparable for rerating.

Risk assessment: Tail risks include a competing bid (10–25% probability given strategic buyers), financing breakdown by sponsor (low but non-zero), or a late FDI/competition reversal despite approvals (very low). Immediate window risk (days) is spread volatility and potential tender restrictions; short term (weeks) is acceptance-rate uncertainty; long term (quarters) is consolidation-driven price power for remaining listed peers. Hidden dependencies: sponsor’s balance-sheet/FX funding (NOK/SEK), and whether the offer is financed with debt that could trigger asset sales.

Trade implications: Primary trade is cash-arbitrage in ARISE.ST during acceptance; if spread to offer >=0.5% execute size-limited longs. Relative-value: long ARISE.ST vs short OX2.ST to isolate deal premium vs sector beta. Options: buy Jan-2026 call spreads or sell puts if offered price is credible; target >8–12% annualized carry for arbitrage. Cross-asset: limited bond/commodities impact; monitor NOK/SEK (small NOK outflow) and Swedish small-cap liquidity tightening.

Contrarian angles: Consensus may price this as a done deal; however acceptance rates often leave 5–15% residual risk — if ARISE trades >1% below offer price for >5 trading days, the market is underpricing possibility of a higher topping bid or extension. Historical parallels (Nordic takeovers 2018–22) show sponsors raising offers late to secure >90% — a late 1–5% bump is plausible. Unintended consequence: lower public project comparables could re-rate remaining listed developers upward over 6–24 months.

Key Decisions for Investors

• Establish a capped 2–3% fund-level long position in ARISE.ST if the stock trades at least 0.5% below the announced cash offer price for three consecutive trading days; target hold until settlement (expected ~12 Jan 2026) and aim for 0.5–1.5% absolute return (annualized >8–12%).
• Implement a pair trade: long ARISE.ST (size X) versus short OX2.ST (size X) to neutralize Nordic renewables beta; trim both positions if acceptance rate >90% by 23 Dec 2025 or if ARISE spread compresses to <0.2%.
• If liquid options exist, sell cash-secured puts on ARISE.ST struck ~2% below offer up to 1% of NAV to collect premium, or buy Jan-2026 call spreads sized to 0.5–1% of NAV if implied vol < realized vol to capture upside from a potential topping bid.
• Reduce new exposure (>25% reallocation) to small-cap Swedish renewable developers (individual positions >1% NAV) for 3–12 months to reflect reduced comparable liquidity and potential M&A-driven rerating; redeploy into larger listed European utilities (e.g., ORSTED.CO) with 6–12 month horizon.
• Monitor three triggers closely: (a) acceptance percentage announcements weekly (raise allocation if <80% by 23 Dec 2025), (b) any rival bid filings (immediate hedge reduction if competing buyer emerges), and (c) sponsor financing notices (pullback if sponsor issues high-yield debt >€200m that could force asset disposals).